49
Participants
Start Date
August 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2029
short course radiotherapy using MR-linac
Patients in the MRgART group will receive standard total neoadjuvant therapy (TNT) and surgical treatment, including short-course radiotherapy and chemotherapy, with the addition of immunotherapy at the investigator's discretion based on individual patient characteristics.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER